Font Size: a A A

Clinical Significance Of Antibiotic Prophylaxis In Perioperative Period Of Intravascular Interventional Therapy

Posted on:2015-04-03Degree:MasterType:Thesis
Country:ChinaCandidate:X L QiuFull Text:PDF
GTID:2284330434456211Subject:Digestive medicine
Abstract/Summary:PDF Full Text Request
Objective:To investigate the protective effect of antibiotic prophylaxis againstpostoperative infection in perioperative period of intravascularinterventional therapy.Methods:Clinical data of inpatients with liver cancer undergoing transarterialchemoembolization(TACE) from January2007to March2013or inpatientswith cirrhosis undergoing transjugularintrahepatic portosystemicshunts(TIPS) from January2011to March2013were collected andretrospectively analyzed. We classified the inpatients into antibioticprophylaxis treatment group and no antibiotic prophylaxis treatment group,compared the postoperative infection rate, and analyzed the risk factors ofinfection.Results:1. There were538patients undergoing TACE, including501malesand37females.The number of patients undergoing TIPS was61,which contained47males and14females.According to antibiotic prophylaxis inperioperative period of intravascular interventional therapy. Thepostoperative infection rate of antibiotic prophylaxis treatment group andno antibiotic prophylaxis treatment group about TACE procedures were16.7%(60/359)and20.1%(36/179) respectively (P=0.33).2. The incidence rate of respiratory tract infection, unexplainedinfection, peritonitis, urinary infection, sepsis, biliary tract infection, liverabscess, pleuritis and the digestive tract infection between TACE antibioticprophylaxis treatment group and TACE no antibiotic prophylaxis treatmentgroup didn,t reach statistical significance(P>0.05).3.Univariate and multivariate analysis indicated that Child-Pughscore and operation time over two hours were independent risk factors.4.The postoperative infection rate of antibiotic prophylaxis treatmentgroup of TIPS procedures was33.3(5/15) and that of no antibioticprophylaxis treatment group was34.8(16/46)(P=0.92).5. The incidence rate of respiratory tract infection, peritonitis, urinaryinfection, sepsis and unexplained infection between TIPS antibioticprophylaxis treatment group and TIPS no antibiotic prophylaxis treatmentgroup didn,t reach statistical significance(P>0.05).6. multivariate analysis showed that age and Child-Pugh score were independent risk factors.Conclusions:Antibiotic prophylaxis in patients with Child-Pugh A undergoing TACEor TIPS therapy is not routinely necessary. However, it is more reasonable touse appropriate antibiotics for the high-risk group who have poor liverfunction, long operation time and advanced age.
Keywords/Search Tags:Primary Hepatocellular Carcinoma, Chemoembolization, Transjugular Intrahepatic Portosystemic Shunt, Infection
PDF Full Text Request
Related items
Diagnostic Value Of Conventional Ultrasound In Detecting Transjugular Intrahepatic Portosystemic Shunt Dysfunction
Transjugular Intrahepatic Portosystemic Shunt With Covered Stent:Technical Aspects And Clinical Applications
The Application Of Transjugular Intrahepatic Portosystemic Shunt In Patients With Hepatocellular Carcinoma Accompanied By Portal Hypertension
Clinical Study On Transjugular Intrahepatic Portosystemic Shunt (TIPS) For The Treatment Of Portal Hypertension Of Patients With Hepatocellular Carcinoma
Efficacy And Safety Of Transjugular Intrahepatic Portosystemic Shunt In The Treatment Of Hepatocellular Carcinoma Complicated With Esophageal And Gastric Varices Bleeding
Study On Hemodynamic Changes And Hepatic Encephalopathy And Stent Dysfunction After Transjugular Intrahepatic Portal Shunt
Transjugular Intrahepatic Portosystemic Shunt With Covered Stents Of Different Diameter For The Prevention Of Esophageal Variceal Rebleeding:A Randomized Controlled Trial
A Basic Applied Study To Evaluate Transjugular Intrahepatic Portosystemic Shunt Through Left Portal Vein With Multi-slice CT Angiography
A Meta-analysis Comparing Covered Stents With Different Diameter In Transjugular Intrahepatic Portosystemic Shunt(TIPS) For The Treatment Of Portal Hypertension In Patients
10 Clinical Efficacy Of Transjugular Intrahepatic Portosystemic Shunt Created With 6-mm Covered Stents For Secondary Prophylaxis Of Esophagogastric Variceal Bleeding In Patients With Cirrhosis